WO2004031364A3 - Proteins associated with cell growth, differentiation, and death - Google Patents

Proteins associated with cell growth, differentiation, and death Download PDF

Info

Publication number
WO2004031364A3
WO2004031364A3 PCT/US2003/031441 US0331441W WO2004031364A3 WO 2004031364 A3 WO2004031364 A3 WO 2004031364A3 US 0331441 W US0331441 W US 0331441W WO 2004031364 A3 WO2004031364 A3 WO 2004031364A3
Authority
WO
WIPO (PCT)
Prior art keywords
death
differentiation
cell growth
proteins associated
cgdd
Prior art date
Application number
PCT/US2003/031441
Other languages
French (fr)
Other versions
WO2004031364A2 (en
Original Assignee
Incyte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Corp filed Critical Incyte Corp
Priority to AU2003279799A priority Critical patent/AU2003279799A1/en
Publication of WO2004031364A2 publication Critical patent/WO2004031364A2/en
Publication of WO2004031364A3 publication Critical patent/WO2004031364A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Various embodiments of the invention provide human proteins associated with cell growth, differentiation, and death (CGDD) and polynucleotides which identify and encode CGDD. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of CGDD.
PCT/US2003/031441 2002-10-03 2003-10-03 Proteins associated with cell growth, differentiation, and death WO2004031364A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003279799A AU2003279799A1 (en) 2002-10-03 2003-10-03 Proteins associated with cell growth, differentiation, and death

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US41620502P 2002-10-03 2002-10-03
US60/416,205 2002-10-03
US42152102P 2002-10-25 2002-10-25
US60/421,521 2002-10-25
US42837602P 2002-11-21 2002-11-21
US60/428,376 2002-11-21
US43625802P 2002-12-23 2002-12-23
US60/436,258 2002-12-23
US43929203P 2003-01-10 2003-01-10
US60/439,292 2003-01-10
US44757803P 2003-02-13 2003-02-13
US60/447,578 2003-02-13

Publications (2)

Publication Number Publication Date
WO2004031364A2 WO2004031364A2 (en) 2004-04-15
WO2004031364A3 true WO2004031364A3 (en) 2005-02-17

Family

ID=32074840

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/031441 WO2004031364A2 (en) 2002-10-03 2003-10-03 Proteins associated with cell growth, differentiation, and death

Country Status (2)

Country Link
AU (1) AU2003279799A1 (en)
WO (1) WO2004031364A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090233982A1 (en) * 2005-03-04 2009-09-17 Michaela Frye Methyltransferases and Their Uses
AU2012202663B2 (en) * 2005-03-04 2014-11-27 Cancer Research Technology Limited Methyltransferases and their uses
US20090305255A1 (en) * 2006-02-01 2009-12-10 Hiroshima University Substrate Protein for M-Phase Kinase and use Thereof
DE102006018392A1 (en) * 2006-04-20 2007-10-25 Neuroprofile Gmbh Therapeutic targets for the development of novel drugs for degenerative diseases
WO2014197535A1 (en) * 2013-06-04 2014-12-11 Virginia Commonwealth University Recombinant cancer therapeutic cytokine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6297030B1 (en) * 1998-12-23 2001-10-02 Smithkline Beecham Plc Human Wnt-7a polynucleotides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6297030B1 (en) * 1998-12-23 2001-10-02 Smithkline Beecham Plc Human Wnt-7a polynucleotides

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BUI T.D. ET AL.: "Isolation of a full-length human WNT7 a gene implicated in limb development and cell transformatoin, and mapping to chromosome 3p25", GENE, vol. 189, April 1997 (1997-04-01), pages 25 - 29, XP004059554 *
CARICASOLE A. ET AL.: "The Wnt pathway, cell-cycle activation and B-amyloid: novel therapeutic strategies in Alzheimer's disease?", vol. 24, no. 5, May 2003 (2003-05-01), pages 233 - 238, XP004427196 *
LUSTIG B. ET AL.: "The Wnt pathway and its role in tumor development", vol. 129, April 2003 (2003-04-01), pages 199 - 221, XP002983435 *
TOLWINSKI ET AL.: "Rethinking WNT signaling", TRENDS IN GENETICS, vol. 20, no. 4, April 2004 (2004-04-01), pages 177 - 181, XP004497327 *

Also Published As

Publication number Publication date
WO2004031364A2 (en) 2004-04-15
AU2003279799A8 (en) 2004-04-23
AU2003279799A1 (en) 2004-04-23

Similar Documents

Publication Publication Date Title
WO2003008553A3 (en) Proteins associated with cell growth, differentiation, and death
WO2003014322A3 (en) Proteins associated with cell growth, differentiation, and death
WO2003094848A3 (en) Nucleic acid-associated proteins
WO2003077875A3 (en) Proteins associated with growth, differentiation, and death
WO2002097060A3 (en) Carbohydrate-associated proteins
WO2004048550A3 (en) Immune response associated proteins
WO2004044165A3 (en) Lipid-associated proteins
WO2002072830A3 (en) Proteins associated with cell growth, differentiation, and death
WO2003047526A3 (en) Cell adhesion and extracellular matrix proteins
WO2003062391A3 (en) Structural and cytoskeleton-associated proteins
WO2003076586A3 (en) Nucleic acid-associated proteins
WO2002097032A3 (en) Proteins associated with cell growth, differentiation, and death
WO2004031364A3 (en) Proteins associated with cell growth, differentiation, and death
WO2002102310A3 (en) Proteins associated with cell growth, differentiation, and death
WO2003095622A8 (en) Proteins associated with cell growth, differentiation, and death
WO2004048529A3 (en) Cell adhesion and extracellular matrix proteins
WO2002066646A3 (en) Neurotransmission-associated proteins
WO2004003162A3 (en) Enzymes
WO2003027263A3 (en) Proteins associated with cell growth, differentiation, and death
WO2004015396A3 (en) Cell adhesion and extracellular matrix proteins
WO2003072729A3 (en) Enzymes
WO2003025542A3 (en) Immune response associated proteins
WO2003050253A3 (en) Proteins associated with cell growth, differentiation, and death
WO2002088322A3 (en) Cell adhesion and extracellular matrix proteins
WO2003094843A3 (en) Cell adhesion and extracellular matrix proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP